ArticleFrontiers in public health2026
Integrating non-communicable disease screening to COVID-19 and human immunodeficiency virus care in Johannesburg South Africa: a pilot model for low- and middle-income countries.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The COVID-19 pandemic underscored the relationship between infectious diseases and non-communicable diseases (NCDs), highlighting increased risks for people with pre-existing chronic conditions. This study piloted an integrated care model for NCD and infectious disease screening in healthcare settings. The aim of this study is to show that integrating NCD screening into existing HIV clinics and COVID-19 vaccine delivery clinics leads to better pandemic preparedness. Methods: From October 2023 to December 2023, we conducted a cross sectional prospective, low interventional study involving 461 participants from two health care clinics in Johannesburg, South Africa using convenience sampling. Screening included blood pressure, body mass index (BMI), HbA1c, lipid profile, glucose, and kidney function assessments. Data were analyzed to identify NCD prevalence and key risk factors. Results: Newly diagnosed NCDs were found in 73.9% of participants. The most common were kidney disease (31.7%), obesity (28.9%), and dyslipidaemia (25.8%). Modifiable cardiovascular disease (CVD) risk factors, including obesity (63.9%) and alcohol use (50%), were widespread. Conclusion: Integrating NCD screening into HIV and COVID-19 services is achievable, offers a valuable opportunity for early detection and intervention. Scaling such models could strengthen health systems in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.